Skip to main content

Advertisement

Log in

CBT MobileWork©: User-Centered Development and Testing of a Mobile Mental Health Application for Depression

  • Original Article
  • Published:
Cognitive Therapy and Research Aims and scope Submit manuscript

Abstract

Background

“Homework assignments,” a critical element of Cognitive Behavioral Therapy (CBT) for depression, are a means of CBT skill generalization and maintenance. Yet, homework adherence is often low. We developed CBT MobileWork,© a smartphone application (app) to promote CBT skills practice “as-needed.”

Methods

We applied a user-centered design in a laboratory setting with 8 depressed patients and 5 therapists for the initial development and testing. We then completed a real-world evaluation of CBT MobileWork© with 15 depressed patients in CBT and their therapists. This report details the prototype development, presents data evaluating feasibility and usability in the lab and real-world, and presents preliminary findings of associated measures.

Results

Our data indicates that both patients and therapists reported high levels of satisfaction and rated the application highly usable during testing in both controlled laboratory and under real-world conditions. A moderate association between app use and reductions in depression was found.

Conclusions

CBT MobileWork© has preliminary feasibility for CBT skills practice and may benefit patients with CBT homework completion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Download references

Acknowledgements

The authors would like to thank The University of Pittsburgh Clinical and Translational Science Institute (CTSI) for the support and training that contributed substantially to this work. This research was supported by National Center for Research Resources of the National Institutes of Health under Award Number KL2TR000146 (PI: Reis) The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. This research was also supported by ClinicalTrials.gov: ClinicalTrials.gov: NCT00118404, NCT00183664, and NCT00218764; Jarrett & Thase, 2010).

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by JC, SS, ADVD, LT and JDJ. The first draft of the manuscript was written by JC and all authors participated in the writing of the manuscript based upon their specific expertise and commented on previous and final versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Judith A. Callan.

Ethics declarations

Conflict of Interest

Judith Callan, Jacqueline Dunbar Jacob, Susan Sereika, Annette Devito Dabbs, Armando Rotondi, Greg Jeremy Siegle, Anind Dey, Lisa Tamres, Ashley Van Slyke declare they have no confict of interest. Michael E. Thase reports no Conflicts of Interest specifically related to this research. In the past 3 years, he reports the following relationships. Advisory/Consultant: Acadia, Inc., Akili, Inc., Alkermes PLC, Allergan, Inc. (Forest, Naurex), Boehringer-Ingelheim, Calla Inc., Clexio Biosciences, H. Lundbeck A/S, Jazz Pharmaceuticals, Janssen (Johnson & Johnson), Otsuka Pharmaceutical Company Ltd, Perception Neuroscience, Sage Therapeutics, Seelos Pharmaceuticals and Takeda Grant Support: Acadia, Inc., Allergan, Inc. (Forest, Naurex), Axsome Therapeutics, Intracellular, Inc., Janssen Pharmaceutica (Johnson & Johnson), Myriad (Assurex), Otsuka Pharmaceutical Company, Ltd., and Takeda. Speakers Bureau: None. Royalties: American Psychiatric Press Incorporated, Guilford Publications, Herald House, and W.W. Norton & Company, Inc. Spouse’s Employment: Peloton Advantage, which does business with a number of pharmaceutical companies. Nikolaos Kazantzis reported being a board member of the International Association of Cognitive Therapy, which has a strategic partnership with the Academy of Cognitive Therapy; being a consultant to the Australian Psychological Society Institute; being an adjunct faculty and receiving personal fees from Beck Institute for Cognitive Behavior Therapy and Research; receiving compensation from SpringerNature; and receiving royalties from SpringerNature, Guilford, and Routledge.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Research Involving Animal Rights

No animal studies were carried out by the authors for this article.

Research Transparency Statement

We report on all conditions, data, exclusions and measures.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 35 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Callan, J.A., Dunbar Jacob, J., Siegle, G.J. et al. CBT MobileWork©: User-Centered Development and Testing of a Mobile Mental Health Application for Depression. Cogn Ther Res 45, 287–302 (2021). https://doi.org/10.1007/s10608-020-10159-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10608-020-10159-4

Keywords

Navigation